IDH3A and astrocytoma (excluding glioblastoma): A previous study found that increased tracer uptake on FAP-specific imaging had the ability to distinguish isocitrate dehydrogenase (IDH)-wild-type glioblastomas and high-grade IDH-mutant astrocytoma [16].